Phase 4
N=37
A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine
Femoro Acetabular Impingement
Bottom Line
View on ClinicalTrials.gov: NCT04114058 ↗Enrolled (actual)
37
Serious AEs
0.0%
Results posted
May 2021
Primary outcome: Primary: Visual Analogue Scale — 2.4; 2.7 cm
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- liposomal bupivicaine (Drug); Fascia iliaca blockade (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Cedars-Sinai Medical Center
- Primary completion
- Mar 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Analogue Scale |
2.4; 2.7 | — |
| SECONDARY Narcotic Utilization |
7.6; 7.8 | — |
| SECONDARY Total Number of at Home Falls. |
0; 6 | — |
Summary
The purpose of this study is to compare the effectiveness of fascia iliaca blockade vs local field infiltration with liposomal bupivicaine in controlling pain, narcotic utilization and falls in the postoperative period following hip arthroscopy
Eligibility Criteria
Inclusion Criteria
- adult patients (>18 years old)
- diagnosed FAI that are indicated for hip arthroscopic labral repair and femoroplasty/acetabuloplasty.
Exclusion Criteria
- patients undergoing revision procedures, bilateral procedures,
- advanced osteoarthritis ( 15 degrees)
- diagnoses other than FAI (Legg Calve Perthes, femoral head avascular necrosis, septic arthritis, or post traumatic deformity).
- allergy to liposomal bupivicaine
Data sourced from ClinicalTrials.gov (NCT04114058). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.